Court Finds That Qui Tam Relator Cannot Enforce 340B Program Statute

Sidley – A recent decision from the Central District of California held that a qui tam relator cannot bring a False Claims Act case against pharmaceutical manufacturers to enforce the 340B Drug Pricing Program’s statutory requirements.